Executing in oncology with investigational BNT327/PM8002 combinations and mRNA cancer immunotherapy candidates as pan-tumor treatment approaches ...

The CEO of BioNTech Ugur Sahin was inoculated in early 2021 with the COVID-19 vaccine his team developed with Pfizer, a ...

Executing in oncology with investigational BNT327/PM8002 combinations and mRNA cancer immunotherapy candidates as pan-tumor treatment approaches BioNTech aims to develop BNT327/PM8002 as a next-genera ...

BioNTech SE operates as immunotherapy company ... 2008 and is headquartered in Mainz, Germany.

More about BioNTech SE BioNTech SE is a biotechnology company based in Mainz, Germany, primarily known for its development of mRNA-based vaccines and immunotherapies. The company is a significant ...

Invest in the best value stocks with Interactive Brokers for quick trade execution. Value stocks/companies consist of companies whose current valuation appears low relative to their fundamentals ...

The Germany-based company has agreed to pay $791.5 million to the U.S. agency, whereas it would pay $467 million to UPenn to dismiss the lawsuit. Moreover, BioNTech's partner Pfizer (PFE ...

General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell, swollen lymph ...

University of Pennsylvania will receive $467 million from BioNTech as part of a settlement in a lawsuit over COVID-19 vaccine royalties, writes John George ...